5 years ago

fool.com.au

The Megaport (ASX:MP1) share price sank 16% lower in October: Time to buy?

5 years ago

proactiveinvestors.com.au

VIP Gloves sees EBITDA rise 340% in September quarter boosted by growing demand and hike in average selling price

5 years ago

fool.com.au

These were the 3 best-performing ASX 200 tech shares in October

5 years ago

proactiveinvestors.com.au

Pharmaxis achieves gold standard as Bronchitol granted FDA approval for US market

5 years ago

proactiveinvestors.com.au

Imugene receives FDA IND approval for phase-1 clinical trial of new checkpoint immunotherapy PD1-Vaxx in USA

5 years ago

proactiveinvestors.com.au

Musgrave Minerals achieves strong Starlight gold recoveries from tests using conventional methods

5 years ago

smallcaps.com.au

Alice Queen to resume drilling at Horn Island, assays pending from previous program

5 years ago

stockhead.com.au

Ora Gold teams up with Sandfire as partner at Red Bore copper project

5 years ago

smallcaps.com.au

Pharmaxis secures US FDA approval for Bronchitol, sales to bankroll development of myelofibrosis drug candidate

5 years ago

stockhead.com.au

Bryah Resources has company-defining ore deposit in its sights